Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials

IMPORTANCE: The association of biomarkers with patient survival after recurrence (SAR) is poorly understood, yet may guide management and treatment. OBJECTIVE: To determine the association of DNA mismatch repair (MMR) status and somatic mutations in BRAF(V600E) or KRAS (exon 2) in the primary tumor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Main Authors: Sinicrope, Frank A., Shi, Qian, Allegra, Carmen J., Smyrk, Thomas C., Thibodeau, Stephen N., Goldberg, Richard M., Meyers, Jeffrey P., Pogue-Geile, Kay L., Yothers, Greg, Sargent, Daniel J., Alberts, Steven R.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498991/
https://ncbi.nlm.nih.gov/pubmed/28006055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.5469
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares